Myomo Reports Fourth Quarter and Year End 2017 Results
CAMBRIDGE, Mass., March 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the fourth quarter and year end December 31, 2017. Read more.
Myomo to Present at the 30th Annual ROTH Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 30th Annual ROTH Conference in Dana Point, CA on Monday, March 12th at 9:00 AM PT, Blue – Salon 2. Chairman and Chief Executive Officer Paul R. Gudonis will be […]
Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference
Cambridge, MA., January 16, 2018 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at NobleCon14 – Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 29th at 11:00 AM EST – Studio […]
Myomo, Inc. Announces Full Exercise of Underwriter’s Over-allotment Option in Follow-on Public Offering
CAMBRIDGE, Mass., December 6, 2017 – Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock and accompanying warrants to purchase 626,250 shares of common stock, at a combined price […]
Myomo Expands MyoPro® Centers of Excellence Program
Growing Nationwide Roster Supports MyoPro Powered Orthosis Cambridge, MA., November 29, 2017 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the […]
Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering
CAMBRIDGE, Mass., November 13, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase […]
Myomo, Inc. Issues November 2017 Shareholder Letter
CAMBRIDGE, Mass., November 7, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities.
Myomo, Inc. Reports Third Quarter 2017 Results
CAMBRIDGE, Mass., November 6, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Read more.
Myomo Enters Canadian Market
Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its […]
Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces
MyoPro® for Veterans is Designed to Broaden MyoPro Accessibility to the Many Veterans Who May Benefit. CAMBRIDGE, Mass., October 17, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical device company, today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered […]